RBS Stock Rating Upgraded by Barclays Capital (RBS)

Share on StockTwits

RBS (LON: RBS) was upgraded by stock analysts at Barclays Capital from an “equal weight” rating to an “overweight” rating in a report issued on Wednesday, Stock Ratings Network reports. The firm currently has a GBX 370 ($5.64) price target on the stock, up from their previous price target of GBX 300 ($4.57). Barclays Capital’s target price would indicate a potential upside of 12.98% from the company’s current price.

RBS has been the subject of a number of other recent research reports. Analysts at Espirito Santo Investment Bank Research reiterated a “sell” rating on shares of RBS in a research note to investors on Monday. They now have a GBX 320 ($4.88) price target on the stock. Separately, analysts at UBS AG reiterated a “buy” rating on shares of RBS in a research note to investors on Friday, June 7th. They now have a GBX 370 ($5.64) price target on the stock. Finally, analysts at BNP Paribas reiterated a “neutral” rating on shares of RBS in a research note to investors on Friday, June 7th. They now have a GBX 320 ($4.88) price target on the stock.

Eight investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have given a buy rating to the company’s stock. RBS currently has a consensus rating of “Hold” and an average target price of GBX 324.87 ($4.95).

RBS (LON: RBS) opened at 330.80 on Wednesday. RBS has a 1-year low of GBX 193.30 and a 1-year high of GBX 370.62. The stock’s 50-day moving average is currently GBX 265.8. The company’s market cap is £36.821 billion.

The Royal Bank of Scotland Group plc (LON: RBS) is a holding company of a global banking and financial services group.

Latest News

Best Buy Stock Up on Earnings Report
Best Buy Stock Up on Earnings Report
FTC and Credit Score Firm Settle Charges
FTC and Credit Score Firm Settle Charges
Xiaomi Share Values IQiyi at $3 Billion
Xiaomi Share Values IQiyi at $3 Billion
Nokia Returns to Consumer Electronics with Android Tablet
Nokia Returns to Consumer Electronics with Android Tablet
Actavis Close to Deal to Acquire Allergan for $64 Billion
Actavis Close to Deal to Acquire Allergan for $64 Billion
Earnings Season Ends This Week with Retailers
Earnings Season Ends This Week with Retailers


Leave a Reply

Advertisement
Advertisement
© 2006-2014 Ticker Report. Google+.